Related Experiment Video
Updated: May 11, 2026

Randomized Controlled Trial to Study the Acute Effects of Strength Exercise on Insulin Sensitivity in Obese Adults
Published on: December 1, 2023
Effects of birth size, post-natal growth and current size on insulin resistance in 9-year-old children: a prospective
Melissa J Whitrow1, Michael J Davies, Lynne C Giles
1Discipline of Obstetrics & Gynaecology, School of Paediatrics & Reproductive Health, The University of Adelaide, Mail Drop 327, Adelaide, SA 5005, Australia. melissa.whitrow@adelaide.edu.au
Insights
Childhood growth impacts insulin resistance (IR). Accelerated growth from birth to age 9, particularly around 3.5 years, may influence later IR risk. Early body size is key for metabolic health.
Area of Science:
- Pediatrics
- Metabolic Health
- Developmental Biology
Background:
- Prenatal conditions can influence later type 2 diabetes risk factors, including insulin resistance (IR).
- Postnatal growth trajectory may mediate the effects of prenatal influences on IR.
- Understanding early growth patterns is crucial for predicting future metabolic health.
Purpose of the Study:
- To investigate the association between body size at birth and age 9 with insulin resistance (IR) at age 9.
- To explore the role of postnatal growth trajectory in mediating the relationship between early body size and later IR.
- To examine potential interactions between birth size and childhood growth on IR development.
Main Methods:
- Prospective Australian cohort study.
- Analysis of body size z-scores (weight or BMI) at birth and age 9.
- Insulin resistance (IR) estimated using homeostasis model assessment (HOMA-IR) at age 9 in 151 children.
Main Results:
- Higher BMI z-score at age 9 was positively associated with IR.
- Birth BMI z-score showed an inverse association with IR only after adjusting for age 9 BMI z-score, suggesting accelerated growth's impact.
- A significant interaction between birth and age 9 BMI z-scores was observed, with potential inverse association between body size at 3.5 years and HOMA-IR at 9 years.
Conclusions:
- Early life growth, from birth to age 9, is important for later insulin resistance.
- Accelerated growth between birth and age 9 may influence insulin resistance.
- The specific growth period around 3.5 years warrants further investigation for its impact on HOMA-IR at age 9.
Abstract:
The influence of pre-natal conditions on later type 2 diabetes risk factors such as insulin resistance (IR) may be mediated by post-natal growth trajectory. We aimed to investigate the association of body size at birth and 9 years with IR at 9 years. Using data from a prospective Australian cohort study, we examined the influence of body size from birth to 9 years [z-score for weight or body mass index (BMI)] on IR at 9 years (estimated by homeostasis model assessment). At age 9 years, 151 children provided a fasting blood sample. z-BMI at age 9 was positively associated with IR. Birth z-BMI was inversely associated with IR only after adjustment for z-BMI at age 9 years. This may be interpreted as an effect of accelerated growth between birth and 9 years on IR. There was a statistically significant interaction between birth and 9-year z-BMI. Results from regression models including z-BMI at all available time points (birth, 6 and 12 months, and 2, 3.5 and 9 years) indicate a possible inverse association between body size at 3.5 years and HOMA-IR at 9 years. Results were similar when the analyses were repeated with z-weight substituted for z-BMI. These results add to the body of evidence concerning the importance of growth in early life for later IR, and highlight a possible interaction between pre- and post-natal growth. The potential influence of growth at around 3.5 years for HOMA-IR at 9 years warrants further investigation.
Related Concept Videos
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational
Type II Diabetes II: Pathophysiology
Type II Diabetes I: Introduction
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Nature and Nurture

